Graham Capital Management L.P. lifted its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 182.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 128,077 shares of the company's stock after purchasing an additional 82,673 shares during the quarter. Graham Capital Management L.P. owned about 0.05% of Oscar Health worth $1,721,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its position in Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after acquiring an additional 8,051,379 shares in the last quarter. BIT Capital GmbH lifted its position in Oscar Health by 5,711.6% in the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after acquiring an additional 4,396,872 shares in the last quarter. Deerfield Management Company L.P. Series C lifted its position in Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after acquiring an additional 3,983,325 shares in the last quarter. Hennessy Advisors Inc. lifted its position in Oscar Health by 550.3% in the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after acquiring an additional 3,544,300 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC lifted its position in Oscar Health by 51.4% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after acquiring an additional 2,151,256 shares in the last quarter. Institutional investors own 75.70% of the company's stock.
Oscar Health Stock Up 5.8%
NYSE:OSCR traded up $0.96 on Friday, hitting $17.52. The stock had a trading volume of 10,504,285 shares, compared to its average volume of 4,189,797. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market cap of $4.39 billion, a P/E ratio of -875.31 and a beta of 1.75. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The firm's fifty day simple moving average is $13.46 and its two-hundred day simple moving average is $14.66.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. The firm had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company's revenue for the quarter was up 42.2% on a year-over-year basis. During the same quarter last year, the business posted $0.62 EPS. Analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
Insider Transactions at Oscar Health
In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director now owns 64,512 shares in the company, valued at $1,059,932.16. This trade represents a 27.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 24.39% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Separately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have issued a hold rating, two have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Oscar Health presently has an average rating of "Hold" and a consensus price target of $20.08.
View Our Latest Report on Oscar Health
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
